With 44 offers, the company enterprise arm of Boehringer Ingelheim was probably the most lively company investor within the European life science market within the final 5 years. The...
With 44 offers, the company enterprise arm of Boehringer Ingelheim was essentially the most energetic company investor within the European life science market within the final 5 years. The...